Schedule 13G ownership disclosure
CRISPR Therapeutics AG
Security class unavailable · CUSIP: H17182108
Event date: 2021-07-30
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 4,265,002
- Percent of class
- 5.6000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001562230-21-000117
- Form type
- SC 13G
- Filer
- CRISPR Therapeutics AG
- CIK
- CIK 1674416
- Filed
- Aug 10, 2021
- Reporting period
- Jul 30, 2021
- Description
- Schedule 13G beneficial ownership